The prescription path
The Class II prescription and the IRS Letter of Medical Necessity are the two biggest conversion barriers in the funnel. The altru.care engine eliminates both in one step.
TL;DR
FDA Class II devices require a physician's prescription. HSA/FSA reimbursement requires a Letter of Medical Necessity (IRS Code Section 213(d)). Most patients can't navigate either on their own, so a $500 device that could cost $357 after pre-tax payment reads as a $500 sticker plus a bureaucratic hurdle. The altru.care async engine resolves both in 3–5 minutes, same day, 50 states. That is the unlock.
FDA regulates tPEMF as a Class II medical device under 21 CFR 890.5740. Class II devices may not be dispensed without a physician's prescription — the same requirement as a prescription drug. This is not a technicality that can be waived or worked around. It is a statutory requirement that applies regardless of where the patient finds the device: online, through a friend, through a surgeon referral. A patient who wants to purchase a SofPulse device needs an active prescription from a licensed physician. If their surgeon didn't write one, they need to find a physician who will — typically requiring a new clinical encounter, which may involve days or weeks of scheduling and an out-of-pocket copay.
Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) are pre-tax accounts that reimburse qualified medical expenses under IRS Code Section 213(d). A device that is 'primarily for medical care' — rather than general health or wellness — qualifies for HSA/FSA reimbursement. For a Class II prescription device, the device clearly qualifies once a Letter of Medical Necessity (LMN) is in place. The LMN documents the patient's diagnosis, the medical rationale for the device, and the ordering physician's credentials. Without an LMN, the patient may attempt reimbursement but faces audit risk from their HSA/FSA administrator. The LMN is the document that converts a wellness purchase into a tax-advantaged medical purchase.
Josh Emdur, DO is licensed in all 50 states — the clinical backbone of the altru.care platform. A patient completes a brief intake form (medical history, surgical details, current medications, pain description): approximately 5–7 minutes. Josh reviews the intake asynchronously, determines medical appropriateness, and issues both the Class II prescription and a compliant LMN: approximately 3–5 minutes of physician time. The patient receives both documents via secure message, same day, without an office visit, without scheduling, without a copay. The prescription is pharmacy-grade and HIPAA-compliant. The LMN is formatted to IRS 213(d) standards. One checkout step, one document package.
A $549 bundled purchase (device + Rx/LMN) made with HSA dollars has an effective cost of $357–384 depending on the patient's marginal tax rate (22–35% bracket). Without the HSA unlock, the patient pays $549 in post-tax income. The difference — $165–192 per patient — is the conversion lever. A patient who was deterred by a $549 sticker becomes a buyer at $357 effective. The LMN + Rx path is not optional friction: it is the mechanism that converts a medical device sale into a tax-advantaged purchase. This is the infrastructure that makes the DTC channel economically compelling for the patient — and it is entirely absent from the current SofPulse distribution model.
At 30 patients per month purchasing through the LMN/HSA path, the channel generates approximately $16,470 in device revenue ($549 × 30) and $1,470 in Rx/LMN fee revenue ($49 × 30). The effective patient cost across that cohort, at an average 28% marginal rate, is approximately $395 — substantially below the sticker. The HSA unlock is not a compliance afterthought; it is the mechanism that makes the channel viable at a price point where the patient's willingness-to-pay meets the device's real cost. Without the LMN, a meaningful portion of those 30 patients would not convert.
Two objections arise from patients. First: 'My HSA/FSA administrator won't approve it.' A Class II Rx device with an IRS-compliant LMN from a licensed physician is a qualified medical expense under Section 213(d). The LMN is formatted specifically to satisfy FSA administrator documentation standards. Second: 'I don't have an HSA.' FSA accounts (offered by approximately 60% of employers with health benefits) follow the same rules and do not require a high-deductible health plan. Patients without either can purchase at full price — the device qualifies on its clinical merits independent of the tax advantage.
Sources & references
Related